Zuzana Romanova

Mrs. Zuzana Romanova

Laboratory of Pharmacological Neuroendocrinology, Institute of Experimental Endocrinology, Biomedical Research Center of the Slovak Academy of Sciences, Slovakia
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ZRZuzana Romanova
Zuzana Romanova
NHNatasa Hlavacova
Natasa Hlavacova
Daniela JezovaDaniela Jezova
Daniela Jezova
There is no doubt that chronic stress accompanied by adrenocortical stress hormone release affects the development and treatment outcome of several mental disorders. Less attention has been paid to the effects of psychotropic drugs on adrenocortical steroids, particularly in clinical studies. This review focuses on the knowledge related to the possible modulation of cortisol and aldosterone secretion under non-stress and stress conditions by antipsychotic drugs, which are being used in the treatment of several psychotic and affective disorders. The molecular mechanisms by which antipsychotic drugs may influence steroid stress hormones include the modulation of central and/or adrenocortical dopamine and serotonin receptors, modulation of inflammatory cytokines, influence on regulatory mechanisms in the central part of the hypothalamic-pituitary axis, inhibition of corticotropin-releasing hormone gene promoters, influencing glucocorticoid receptor-mediated gene transcription, indirect effects via prolactin release, alteration of signaling pathways of glucocorticoid and mineralocorticoid actions. Clinical studies performed in healthy subjects, patients with psychosis, and patients with bipolar disorder suggest that single and repeated antipsychotic treatments either reduce cortisol concentrations or do not affect its secretion. A single and potentially long-term treatment with dopamine receptor antagonists, including antipsychotics, has a stimulatory action on aldosterone release.

4 March 2022 in Steroids
Verified
Journal Article
Closed access
ZRZuzana Romanova
Zuzana Romanova
KHK. Hrivikova
K. Hrivikova
IRI. Riecansky
I. Riecansky
Daniela JezovaDaniela Jezova
Daniela Jezova

15 April 2023 in Pharmacological Reports
Verified
Journal Article
Closed access
PDF file
Eliyahu DremencovEliyahu Dremencov
Eliyahu Dremencov
DGDaniil Grinchii
Daniil Grinchii
ZRZuzana Romanova
Zuzana Romanova
PCPavol Chomanic
Pavol Chomanic
LLLubica Lacinova
Lubica Lacinova
DJDaniela Jezova
Daniela Jezova

21 June 2022 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
ZRZuzana Romanova
Zuzana Romanova
LKL. Karailievova
L. Karailievova
AGA. Garafova
A. Garafova
NHN. Hlavacova
N. Hlavacova
HOH. Oravcova
H. Oravcova
Daniela JezovaDaniela Jezova
Daniela Jezova

25 June 2022 in European Pharmaceutical Journal
Verified
Journal Article
Open access
PDF file
ZRZuzana Romanova
Zuzana Romanova
EKEva Kornanova
Eva Kornanova
AGAlexandra Garafova
Alexandra Garafova
MBMiroslav Borovsky
Miroslav Borovsky
Daniela JezovaDaniela Jezova
Daniela Jezova
A strongly psychosocially demanding situation in the life of a woman is the option of medically indicated abortion. Here we present the design of an ongoing study aiming to examine the stressfulness of life events related to medically indicated abortions by measuring cortisol concentrations in the participants’ hair and saliva. Pilot results show high salivary cortisol concentrations in the majority of the women one day before induced abortion. In half of the group, two months after the abortion, hair cortisol concentrations were higher in comparison to cumulative values from two months before. There were no changes in the second half.

3 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
ZRZuzana Romanova
Zuzana Romanova
AGAlexandra Garafova
Alexandra Garafova
MPMiriam Petrova
Miriam Petrova
EKEva Kornanova
Eva Kornanova
MBMiroslav Borovsky
Miroslav Borovsky
Daniela JezovaDaniela Jezova
Daniela Jezova
PurposePregnancy loss is likely to be a stressful experience associated with negative consequences on behavior and mental health. This pilot study has investigated the assumption that steroid stress hormones (cortisol, testosterone) in hair serve as reliable objective markers of the distress induced by late termination of pregnancy.MethodsThis was a pilot prospective cohort observational study involving 22 women undergoing pharmacologically induced mid-trimester medically indicated termination of pregnancy. They were examined twice, before the abortion at the hospital and two months later at a research clinic (follow-up). Cumulative cortisol and testosterone concentrations in hair samples (2 cm proximal to the scalp), salivary stress markers, and stress coping strategies were assessed. Psychological assessments included the State-Trait Anxiety Inventory (STAI), Coping Inventory for Stressful Situations (CISS), Beck Depression Inventory (BDI), and Eight State Questionnaire (8SQ).ResultsRetrospective cumulative concentrations of testosterone and cortisol in hair were increased two months post-abortion compared to the values in samples taken at the hospital. The salivary alpha-amylase to cortisol ratio was significantly higher two months following abortion. The participants at the follow-up visit showed increased anxiety, but better stress coping, demonstrated by higher positive task-oriented coping strategies. Salivary testosterone and the testosterone/cortisol ratio showed a positive correlation with neuroticism scores at the follow-up visit.ConclusionThe results show that cumulative stress hormone concentrations in hair are reliable objective markers of the real-life stress situation across the post-abortion period. These findings introduce a novel concept that hair testosterone may be associated with emotional vulnerability, such as neuroticism, during the post-abortion period.